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Summary The aim of the present investigation was to evaluate the predictive value
of a symptom-limited exercise test in predicting postoperative morbidity and
mortality in patients submitted to pneumonectomy.
The study was conducted in 150 patients (mean age, 57.1). Forty-four patients
(29.3%) had postoperative complications. Four patients (2.7%) died within one month
of the pneumonectomy. Patients with complications had significantly lower VO2max.
The incidence of complications in relation to the amount of oxygen consumption
showed that with the progressive decrease of oxygen consumption there was a
progressive increase in frequency of complications. In particular patients with VO2max
o50% of predicted should be considered at high risk of morbidity and mortality from
cardiopulmonary causes.
This predictive capacity of VO2max was more evident in patients with a
preoperative FEV1 less than 70% of predicted. The present data support the
suggestion that exercise testing could be a useful adjunt in the evaluation of
postoperative risk for pneumonectomy, especially in patients with obstructive
pulmonary disease.
& 2003 Elsevier Ltd. All rights reserved.
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Introduction
Many studies have evaluated criteria for predicting
postoperative mortality and cardiopulmonary com-
plications after lung resection: they include spiro-
metry, determination of lung diffusing capacity for
CO, arterial blood gas measurement and radio-
nuclide lung scanning.1 There has been debate
about the clinical significance of exercise testing in
preoperative evaluation of patients candidate to
lung resection, and conflicting results have been
reported in the literature concerning the usefulness
of symptom-limited exercise testing. Moreover,
different exercise parameters and different recom-
mendations were given in different studies.1
The aim of the present investigation was to study
the value of a symptom-limited exercise test in
predicting postoperative morbidity and mortality in
patients with non-metatstatic bronchogenic carci-
noma scheduled for pneumonectomy.
Patients and methods
We studied 150 patients who underwent elective
pneumonectomy for bronchogenic carcinoma from
1992 to 2000. There were 141 males and 9 females.
The mean age was 57.1 years (range 33–79). Seven
patients (4.6%) were more than 70 years old, and
95% were smokers (mean pack year, 28).
Thirty patients (20%) had cardiovascular disease:
hypertension (67%), arrhythmia (17%), ischemic
heart disease (20%). Thirty-six patients (17.5%)
had a previously diagnosed respiratory disease
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(chronic obstructive pulmonary disease), and 15.5%
had been submitted to neoadjuvant chemotherapy
prior to lung resection. Cardiopulmonary complica-
tions were defined as: respiratory failure requiring
oxygen supplementation, lobar atelectasis, cardiac
arrhythmia requiring therapy, pneumonia, non-
cardiogenic pulmonary edema, pulmonary embo-
lism. Postoperative death was defined as one
occurring within 30 days of surgery or beyond that
period if the patient had not left the hospital. All
patients were examined with spirometry, radio-
nuclide lung scanning, and arterial gas tension at
rest and after exercise.
A multistage test (25W at 3-min intervals) was
performed on an upright cycle ergometer at a pedal
frequency of 60 rpm with expired gases and minute
ventilation (VE) measured, breath by breath, using
a mass spectrometer (Amis 2000, Innovision,
Odense, Denmark) to determine oxygen consump-
tion, CO2 production, minute ventilation, alveolar
ventilation, and the physiologic dead space to tidal
volume ratio. Patients exercised to exhaustion or to
the occurrence of predefined criteria for termina-
tion of the test.
Results
Forty-four (29.3%) had transient postoperative
complications. Specifically, 36 had only one com-
plication (17 atrial fibrillation, 10 pneumonia, 8
respiratory failure, and 1 pulmonary embolism),
and 8 had more than one complication. There were
4 postoperative deaths within 1 month: 3 because
of respiratory failure and 1 due to pulmonary
embolism. Age, sex, stage of disease, smoking,
histologic type of tumor, preexisting pulmonary or
cardiac disease and side of resection, preoperative
PaO2 and CO2, and predicted postoperative FEV1
were not significantly associated with the develop-
ment of pulmonary complications.
Patients without complications showed a signifi-
cantly higher VO2max (ml kg
1min1 % pred.)
(75.6%71.3 vs. 71%71.8, Po0:05) than observed
in patients with complications. This predictive
capacity of VO2max (ml kg
1min1 % pred.) was
more evident when we compared non-complicated
with complicated patients but with a preoperative
FEV1 less than 70% of predicted (non-complicated
73.5%72.1 vs. complicated 59%74.9, Po0:005).
Finally, the incidence of complications in relation
to the amount of oxygen consumption was evalu-
ated. As shown in Table 1, with the progressive
decrease of oxygen consumption there was a
progressive increase in frequency of complications.
Three of the 4 patients who died had a VO2max
(ml kg1min1) o50% of predicted.
Discussion
Most complications and deaths after pneumonect-
omy are cardiorespiratory. The possibility to better
identify patients at risk of complications is there-
fore very useful.2 Many variables have been used to
assess the risk of postoperative complications:
spirometry and radionuclide scans (which are
considered to accurately estimate postoperative
pulmonary function) lack adequate sensitivity or
specificity for cardiopulmonary postoperative com-
plications.1 In fact, in our study, it was confirmed
that spirometric results and predicted postpneu-
monectomy variables, in particular ppoFEV1, are
not useful for the prediction of postoperative
complications.
There has been debate about the clinical
significance of exercise testing in preoperative
evaluation, and conflicting results have been
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Table 1 Distribution of patients with complications in relation to oxygen maximal consumption expressed as
ml kg1min1 % pred. and lmin1 % pred. at the exercise test.
All:150 FEV1470:114 FEV1o70:36
c/no. (%) c/no. (%) c/no. (%)
VO2maxml kg
1min1% pred
X70 22/92 (24) 19/72 (26) 3/20 (15)
69–50 16/46 (35) 13/35 (37) 3/11 (27)
o50 6/12 (50) 3/7 (43) 3/5 (60)
VO2max lmin
1% pred
X70 13/58 (22) 12/49 (24) 1/9 (11)
69–50 19/59 (32) 16/43 (37) 3/16 (18)
o50 12/33 (36) 7/22 (32) 5/11 (45)
c; number of patients with complications; no., total patients.
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reported in the literature about the applicability of
a symptom-limited exercise. According to some
authors, the exercise test is a good predictor of
postoperative complication, but according to
others it is not.1,3–6
The present study confirmed that VO2max (lmin
1
or ml kg1min1), expressed as a percentage of the
predicted, discriminated between patients suffer-
ing from complications and those who did not,
particularly when a chronic obstructive pulmonary
disease (FEV1 less than 70% of predicted) occurred.
We found that a VO2max (lmin
1 or
ml kg1min1) o50% of predicted is associated
with a very high risk of complications after
pneumonectomy. In the present study, V02max
measured in ml kg1min1 and expressed as per-
centage of predicted seems to be a better single
indicator of complications after lung resection than
VO2max measured in lmin
1 and expressed as
percentage of predicted.
Unfortunately, it was not possible to identify a
clear cutoff limit that separated all the dying
patients from the survivors. In fact, three of the
four patients who died had a VO2max
(ml kg1min1) less than 50% of predicted (sensi-
tivity 75%), and 137 of the 146 patients still alive
were above this limit (93.8% specificity). Similarly,
3 of the 4 patients who died had a VO2max (lmin
1)
less the 50% of predicted (75% sensitivity), and 116
of 146 were above this limit (79.5% specificity). This
result is in agreement with studies previously
reported in the literature.6
In conclusion, cardiopulmonary exercise testing
which evaluates the integrated performance of the
respiratory and the cardiovascular system can
be useful to evaluate the risk of postoperative
complications since exercise induces or amplifies
abnormalities not readily evident at rest. We
therefore recommend routine exercise testing for
the evaluation of patients candidate to pneumo-
nectomy, particularly when FEV1 is less than 70% of
predicted, since the information obtained by the
test gives the clinician additional useful data on
which to base a clinical decision.
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